|
|
|
|
| Join Advancing RNA Chief Editor Anna Rose Welch on March 26 at 11 am ET for Advancements in gRNA Manufacturing & Quality. In this discussion with our knowledgeable panelists, we’ll dig into where the biggest gaps remain in our understanding of guide RNA quality and what improvements to the analytical toolbox/manufacturing paradigm need to be made to improve the overall understanding and quality of guide RNA. Register for free today. |
|
|
|
|
By Anna Rose Welch, Editorial & Community Director, Advancing RNA | Welcome to Advancing RNA’s mRNA Hot Takes, the show where we talk about serious RNA things, but with a spicy twist. Here, in episode 3, Advancing RNA's ARW sits down with Radar Therapeutics' Sophia Lugo and Entrée Bio's Michelle Lynn Hall to call out the "hyped" and "not hyped enough" topics of conversation for the RNA space in 2026. | |
|
|
2026 RNA Investment Landscape: Recent Deals, IPOs, And Venture Trends | William Soliman, Ph.D., BCMAS, White Manna Capital | As RNA investing matures, capital is flowing toward delivery, durability, and regulatory credibility. This column breaks down the deals, IPO signals, and venture theses shaping RNA’s 2026 winners—and why. |
|
|
|
|
|
|
| Reducing Technical Risk In mRNA Therapeutic Development | Article | Roche CustomBiotech | Advancements in purification and delivery mechanisms are essential for the future of mRNA. Improving stability during storage and transport helps mitigate risk and ensures therapeutic efficacy. |
|
|
|
|
|
|
|
| 5th Circular & Self‑Amplifying RNA Therapeutics Summit | This May, the 5th Circular & Self‑Amplifying RNA Therapeutics Summit is returning to Boston. This is the only meeting dedicated exclusively to circular and self‑amplifying RNA, bringing together senior biotech and pharma leaders working on next‑generation RNA therapeutics. As an Advancing RNA subscriber, you get 10% off! Just use code AdvancingRNA10 at checkout to enjoy a discount on all tickets. |
|
|
|
|
|
|
.png){kind=logo}
